In DaBlaCa-13, intravesical mitomycin C reduced procedural burden and matched TURBT outcomes in select recurrent NMIBC patients.
The latest breakthroughs, research highlights, and industry developments in oncology.
Bladder Cancer
Blood-Based Tests
Breast Cancer
Cancer Types